Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2 dy/2j dystrophic mice (Q44949025)

7 December 2017

title

Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2 dy/2j dystrophic mice (English)

1 reference

7 December 2017

6

1 reference

7 December 2017

11

Mayana Zatz

1 reference

7 December 2017

Elen H Miyabara

9

0 references

Oswaldo Keith Okamoto

object named as

Oswaldo K Okamoto

10

0 references

Mariz Vainzof

object named as

Mariz Vainzof

8

0 references

author name string

Mariane Secco

1

1 reference

7 December 2017

Carlos Bueno

2

1 reference

7 December 2017

Natassia M Vieira

3

1 reference

7 December 2017

Camila Almeida

4

1 reference

7 December 2017

Mayra Pelatti

5

1 reference

7 December 2017

Paolo Bartolini

7

1 reference

7 December 2017

language of work or name

1 reference

1 February 2013

1 reference

Stem Cell Reviews and Reports

7 December 2017

published in

1 reference

7 December 2017

volume

9

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

93-109

1 reference

https://scigraph.springernature.com/pub.10.1007/s12015-012-9380-9

7 December 2017

exact match

0 references

cites work

Dystrophin and muscular dystrophy: past, present, and future

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

68th ENMC international workshop (5th international workshop): On congenital muscular dystrophy, 9-11 April 1999, Naarden, The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Muscular dystrophies: genes to pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Muscling in: Gene therapies for muscular dystrophy target RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Optimizing mesenchymal stem cell-based therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

IGF-1, inflammation and stem cells: interactions during muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Animal models for genetic neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Mesenchymal stromal cells: facilitators of successful transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

The MSC: an injury drugstore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9380-9

IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice

21 January 2018

1 reference

12 December 2020

Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog

1 reference

12 December 2020

The muscular dystrophies

1 reference

12 December 2020

Multipotent Stem Cells from Umbilical Cord: Cord Is Richer than Blood!

1 reference

12 December 2020

Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle

1 reference

12 December 2020

Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin

1 reference

12 December 2020

A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success

1 reference

12 December 2020

Phenotypes in golden retriever

1 reference

12 December 2020

10.1007/S12015-012-9380-9

Identifiers

DOI

1 reference

7 December 2017

1 reference